Fundies.
English

Northwest Biotherapeutics, Inc.

EDGAR
NWBO Current report (8-K) · filed 2026-10-30

Annual consolidated revenue for 2025: about Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.378M, using the latest reported figures. The previous period, 2024, was about Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.382M.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments
Watchlist

Latest quarter

Revenue

807 thousand Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg

2026 Q2 · Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg

Exact inputs and evidence
  • Revenue: 807000 Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg Source

Operating margin

-1,438.04%

2026 Q2 · %

Exact inputs and evidence
  • Operating Income: -11605000 Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg Source
  • Revenue: 807000 Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg Source
Cash and cash equivalents
595 thousand Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg Source
Exact value

595000 Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg

Long-term debt including current maturities
52 million Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg Source
Exact value

51973000 Unit_Standard_USD_AVmAK5XDQUmmdcJCyQHjZg

Shares outstanding
1.67 billion Unit_Standard_shares_80mY4PGyFk2cRp80Uyllkg Source
Exact value

1669300000 Unit_Standard_shares_80mY4PGyFk2cRp80Uyllkg

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • Revenue: 2 of 11 periods available· newest 2025-12-31
  • Operating income: 2 of 11 periods available· newest 2025-12-31
  • Net income: 2 of 11 periods available· newest 2025-12-31
  • Operating cash flow: 2 of 11 periods available· newest 2025-12-31
  • Capital expenditure: 2 of 11 periods available· newest 2025-12-31
  • Total assets: Multiple units; comparison withheld· newest 2025-12-31
  • Total liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Current assets: Multiple units; comparison withheld· newest 2025-12-31
  • Current liabilities: Multiple units; comparison withheld· newest 2025-12-31
  • Cash and cash equivalents: Multiple units; comparison withheld· newest 2025-12-31
  • Long-term debt including current maturities: Multiple units; comparison withheld· newest 2025-12-31
  • Shares outstanding: Multiple units; comparison withheld· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Revenue

    -0.3%

    Prior period

    Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.38 million

    –

    Current period

    Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.38 million

    –

    Exact inputs and evidence

    1378000 − 1382000 = -4000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

    1382000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1378000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Net income

    +Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 23.62 million

    Prior period

    −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 83.78 million

    –

    Current period

    −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 60.16 million

    –

    Exact inputs and evidence

    -60162000 − -83778000 = 23616000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

    -83778000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -60162000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    +Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 12.25 million

    Prior period

    −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 57.02 million

    –

    Current period

    −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 44.76 million

    –

    Exact inputs and evidence

    -44763000 − -57017000 = 12254000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

    -57017000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    -44763000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +48.3%

    Prior period

    Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.01 million

    –

    Current period

    Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.5 million

    –

    Exact inputs and evidence

    1504000 − 1014000 = 490000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

    1014000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2024-01-01 – 2024-12-31

    Inspect prior input Prior source

    1504000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g · 2025-01-01 – 2025-12-31

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2025 2025-01-01 – 2025-12-31

  • Revenue Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.38 million 100% of revenue
  • Operating costs Derived Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 61.29 million 4,448% of revenue
  • Operating income −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 59.91 million −4,348% of revenue
  • Tax, interest and other Derived Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 248,000 18% of revenue
  • Net income −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 60.16 million −4,366% of revenue

Cash

  • Operating cash flow −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 44.76 million −3,248% of revenue
  • Capital expenditure Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.5 million 109% of revenue
  • Free cash flow Derived −Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 46.27 million −3,358% of revenue

Share of revenue by period

  • Net income
  • Tax, interest and other
  • Operating costs
  • 2024 Operating loss: operating costs were 4,912% of revenue.
  • 2025 Operating loss: operating costs were 4,448% of revenue.
Values and sources
Revenue breakdown by annual reporting period
PeriodRevenueOperating costsOperating incomeTax, interest and otherNet incomeFree cash flowSource
2024 2024-01-01 – 2024-12-311382000 67890000 Derived -66508000 17270000 Derived -83778000 -58031000 Derived
Source
2025 2025-01-01 – 2025-12-311378000 61292000 Derived -59914000 248000 Derived -60162000 -46267000 Derived
Source

Amounts are exact, in Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.4M 2025
Revenue historyRevenue reported for each complete financial period. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.1.5M1.1M746.3K373.1K0.020242025
Values and sources
Revenue values and source evidence
PeriodSeriesValue(Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g)Source evidence
2024Revenue1382000
2025Revenue1378000

Revenue growth

Change in revenue from the same financial period one year earlier.

-0.3% 2025
Revenue growth historyChange in revenue from the same financial period one year earlier. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.0.023%-0.061%-0.145%-0.229%-0.313%20242025
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence
2024Year over yearNo prior comparable period
2025Year over year-0.3%

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -4,347.9% 2025
Net margin -4,365.9% 2025
Free cash flow margin -3,357.5% 2025
Profit margins historyOperating income, net income and free cash flow as a share of revenue. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.485%-1,273%-3,031%-4,789%-6,547%20242025
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence
2024Operating margin-4,812.4%
2025Operating margin-4,347.9%
2024Net margin-6,062.1%
2025Net margin-4,365.9%
2024Free cash flow margin-4,199.1%
2025Free cash flow margin-3,357.5%

Operating cash flow

Cash generated by the company’s normal business operations.

Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g -44.8M 2025
Operating cash flow historyCash generated by the company’s normal business operations. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.6M-12.0M-28.5M-45.0M-61.6M20242025
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g)Source evidence
2024Operating cash flow-57017000
2025Operating cash flow-44763000

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g -46.3M 2025
Free cash flow historyOperating cash flow minus capital expenditure for the same period and unit. Values are shown by financial reporting period. Open Values and sources below for the exact observations and evidence.4.6M-12.2M-29.0M-45.8M-62.7M20242025
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g)Source evidence
2024Free cash flow-58031000
2025Free cash flow-46267000

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Liabilities / assetsNot reportedNo source recorded
2025-12-31Liabilities / assetsNot reportedNo source recorded

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence
2024-12-31Current assets / current liabilitiesNot reportedNo source recorded
2025-12-31Current assets / current liabilitiesNot reportedNo source recorded

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2024 2024-01-01 – 2024-12-31
−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 83.78 million
Exact value

Exact value: -83778000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2024-01-01 – 2024-12-31: -83778000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 57.02 million
Exact value

Exact value: -57017000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2024-01-01 – 2024-12-31: -57017000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.01 million
Exact value

Exact value: 1014000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2024-01-01 – 2024-12-31: 1014000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 58.03 million
Calculation and evidence

-57017000 − 1014000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

Exact free cash flow: -58031000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2025-01-01 – 2025-12-31
−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 60.16 million
Exact value

Exact value: -60162000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2025-01-01 – 2025-12-31: -60162000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 44.76 million
Exact value

Exact value: -44763000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2025-01-01 – 2025-12-31: -44763000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 1.5 million
Exact value

Exact value: 1504000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

2025-01-01 – 2025-12-31: 1504000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g 46.27 million
Calculation and evidence

-44763000 − 1504000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

Exact free cash flow: -46267000 Unit_Standard_USD_iPVbmvNbYUWkwfDU3mp69g

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

140 filings · 5,363 latest values · 5,363 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001072379, 1072379, NWBO, edgar:1072379, nwbo, nwboob

Also known as NORTHWEST BIOTHERAPEUTICS INC, NORTHWEST BIOTHERAPEUTICS, INC., NORTHWEST BIOTHERAPEUTICS, INC, NORTHWEST BIOTHERAPEUTICS, INC., Northwest Biotherapeutics, Inc.